Metabolic adaptation is a key feature for the virulence of pathogenic intracellular bacteria. Nevertheless, little is known about the pathways in adapting the bacterial metabolism to multiple carbon sources available from the host cell. To analyze the metabolic adaptation of the obligate intracellular human pathogen Chlamydia trachomatis, we labeled infected HeLa or Caco-2 cells with 13 C-marked glucose, glutamine, malate or a mix of amino acids as tracers. Comparative GC-MS-based isotopologue analysis of protein-derived amino acids from the host cell and the bacterial fraction showed that C. trachomatis efficiently imported amino acids from the host cell for protein biosynthesis. FT-ICR-MS analyses also demonstrated that label from exogenous 13 C-glucose was efficiently shuffled into chlamydial lipopolysaccharide probably via glucose 6-phosphate of the host cell. Minor fractions of bacterial Ala, Asp, and Glu were made de novo probably using dicarboxylates from the citrate cycle of the host cell. Indeed, exogenous 13 C-malate was efficiently taken up by C.
Introduction
Chlamydia trachomatis causes sexually transmitted diseases and the ocular scarring disease 'trachoma' with hundreds of millions of cases per year worldwide (Wright et al., 2008; World Health Organization, 2011) . These Gram-negative bacteria undergo a biphasic intracellular developmental cycle that is initiated by the attachment and invasion of so-called elementary bodies (EB), non-dividing infectious chlamydial particles. Internalized EB are taken up into endosomes, which are rapidly modified to avoid lysosomal degradation (Hackstadt et al., 1997) . Within the boundary of the pathogen containing vacuole called inclusion, EB differentiate into dividing reticulate bodies (RB). After several rounds of divisions, the RB re-differentiate into EB and the progeny is released by host cell lysis or exocytosis.
Adaptation of the metabolism to the intracellular environment is crucial for bacterial replication and is therefore linked to virulence (Price et al., 2014; Eisenreich et al., 2015; Abu Kwaik and Bumann, 2015) . C. trachomatis is an obligate intracellular bacterium and provides a prime example of metabolic adaptation for a bacterium obviously relying entirely on its host as replicative niche. Due to the limited genetic accessibility of Chlamydia (Wang et al., 2011) and its obligate intracellular lifestyle, our knowledge on the chlamydial metabolism is rather incomplete. However, based on the sequence of the 1.04 Mb C. trachomatis genome, several metabolic pathways of this aerobic or potentially microaerophilic microorganism can be predicted (Stephens et al., 1998) . Central carbon metabolism seems to be composed of an intact glycolytic pathway, the pentose phosphate pathway (PPP) and a partial citrate (TCA) cycle (Stephens et al., 1998; Nicholson et al., 2004) (Fig. 1 ; Supporting Information Table S1 ). Existence of PEP carboxykinase (PckA, converting oxaloacetate into PEP) may allow the usage of glutamine/glutamate or dicarboxylic acids of the TCA cycle as additional carbon sources and each of these carbon sources was suggested to play stage specific roles (Stephens et al., 1998; Nicholson et al., 2004) . Indeed, growth of C. trachomatis in cell culture was possible with glutamate, malate, 2-oxoglutarate or oxaloacetate as major carbon source, although chlamydial replication rate was reduced by several logs in comparison to the rate with glucose as the major carbon source (Iliffe-Lee and McClarty, 2000) indicating that a gluconeogenic pathway is not functional in intracellular C. trachomatis. In agreement with this hypothesis, a conventional fructose-1,6-bisphosphatase appears to be missing.
Further highlighting the importance of sugars for intracellular C. trachomatis, the gene coding for a glucose 6- Fig. 1 . Reconstruction of the central carbon metabolism of Chlamydia trachomatis based on published genomic data. Chlamydia does not encode glucose uptake systems but the glucose-6P transporter UhpC. Glucose is metabolized via the pentose phosphate pathway (PPP, blue arrows) and glycolysis (GL, orange arrows). In the absence of most amino acid synthesis steps with the exception of mDAP and Trp (without TrpDE), glucose appears to be largely channeled into fatty acids/lipids as well as into the cell wall components, peptidoglycan and LPS. A partial TCA cycle (olive-green arrows) leading from oxoglutarate to oxaloacetate could provide TCA intermediates. The reaction catalysed by PEP carboxylase PckA (magenta arrow) connects the partial TCA with glycolysis. Putative transporters of host nutrients are indicated by green arrows and boxes. Major products of bacterial metabolism including ATP and reduction equivalents are indicated by red arrows and boxes.
phosphate transporter (UhpC) as well as genes coding for key enzymes in glycolysis and the PPP were expressed throughout the developmental cycle. This clearly indicates usage of host cell-derived glucose 6-phosphate (glucose-6P) (Iliffe-Lee and McClarty, 1999; Schwoppe et al., 2002) and host cell-supplied glucose-6P was suggested to serve glycogen biosynthesis (IliffeLee and McClarty, 1999; Iliffe-Lee and McClarty, 2000) . Indeed, glycogen metabolizing enzymes have been described for C. trachomatis (Stephens et al., 1998; Read et al., 2000) . Interestingly, intracellular accumulation of glycogen has been shown in the presence of glucose but not glutamate as the major carbon source in the culture medium (Weigent and Jenkin, 1978; IliffeLee and McClarty, 2000) , also supporting the apparent absence of gluconeogenesis.
The connections between glycolysis and the partial TCA cycle appear to operate unidirectionally since PckA catalyzes the formation of PEP from oxaloacetate, but not vice versa and a pyruvate carboxylase (converting pyruvate into oxaloacetate) is apparently missing (Fig.  1) . Moreover, acetyl-CoA cannot be shuffled into the TCA cycle since the citrate synthase is absent. The formation of succinate by 2-oxoglutarate dehydrogenase (Suc) is also unidirectional since a gene homologous to an oxoglutarate synthase is missing in the chlamydial genome.
Most biosynthetic pathways for amino acids are also missing on the basis of the C. trachomatis genome (Stephens et al., 1998; Read et al., 2000) . Chlamydial replication therefore requires the exogenous supply of amino acids (Bader and Morgan, 1958) . More specifically, various strains of C. trachomatis commonly require glutamine, histidine, phenylalanine, leucine and valine to grow (Allan and Pearce, 1983) when host cells and bacteria compete for amino acid pools (Hatch, 1975a; Harper et al., 2000) . Some Chlamydia species including C. trachomatis encode the biosynthetic pathway for A1g-type peptidoglycan (Pilhofer et al., 2013; Liechti et al., 2014) with meso-diaminopimelate (mDAP) as a crosslinker (Packiam et al., 2015) . Thus, the genes coding for enzymes converting aspartate into mDAP, but not further into lysine, are present in the genome of C. trachomatis.
As expected for this minimalized metabolism, C. trachomatis carries uptake systems for ATP, GTP, CTP, UTP, and NAD in the inner and outer membrane (see also Fig. 1 ) (Sarov and Becker, 1971; Hatch, 1975b; Hatch et al., 1982; Tjaden et al., 1999; Jones et al., 2000; Stephens, 2000, 2001; Fisher et al., 2013) .
Here, we used trachomatis. The data indicate the usage of cosubstrates in a metabolism that appears to be highly adapted to the intracellular environment.
Results
Differential usage of exogenous 13 C-glucose or glutamine by HeLa and Caco-2 cells A detailed understanding of the metabolic pathways and fluxes in host cells is a prerequisite to interpret the isotopic signatures obtained from 13 C-labeling experiments when these cells are infected by intracellular bacteria. Indeed, metabolic fluxes in various established cell lines that can be infected by intracellular bacteria are known to differ due to the expression status of the various signaling pathways, proto-oncogenes and tumor suppressors (Eisenreich et al., 2013) . For the present study of the carbon metabolism of intracellular growing C. trachomatis and the effect of the bacterial infection on the host cell metabolism, we focused on the established human epithelial cancer cell lines, HeLa and, for comparison in some cases, Caco-2. In order to determine the basic carbon pathways of these host cells under the experimental conditions of the infection experiments (see below), we cultivated HeLa or Caco-2 without infection for three passages in RPMI-1640 medium containing 10 mM [U-
13
C 6 ]glucose in addition to 2 mM unlabeled glutamine. The labeled cells were then lysed and the pellet containing insoluble membrane-bound proteins was hydrolyzed under acidic conditions. The resulting amino acids were converted into tert-butyldimethylsilyl (TBDMS)-derivatives which were finally analyzed by GC/MS using established protocols (Eylert et al., 2008) . As expected, essential amino acids such as phenylalanine, valine, threonine, leucine, isoleucine, lysine, and histidine were not labeled from 13 C-glucose (Supporting Information Tables S2 and S3; control) . In contrast, the 13 C-label was quite efficiently transferred to non-essential amino acids, mainly to Ala, Asp and Glu. Notably, these amino acids directly reflect the signatures of central metabolic intermediates. Specifically, Ala is derived by transamination from pyruvate and therefore shows the isotopic pattern of pyruvate mainly deriving from glycolysis and/or the PPP. Asp is made from oxaloacetate via the TCA cycle or via carboxylation of pyruvate by pyruvate carboxylase (PYC). Glu is metabolically related to 2-oxoglutarate derived from acetyl-CoA and oxaloacetate via citrate in the TCA cycle or from glutamine via glutaminolysis, respectively. Capitalizing on these metabolic relationships, the labeling profiles of Ala, Asp and Glu allowed considerable insights into the core metabolic fluxes of the cells under study.
With [U- 13 C 6 ]glucose as the labeled carbon source, 13 C-incorporation into Ala, Asp and Glu was significantly different when comparing the cell type, i.e. using HeLa or CaCo-2 cells. More specifically, the same growth conditions, i.e. growth in RPMI medium containing 10 mM [U-13 C 6 ]glucose and 2 mM unlabeled glutamine, resulted in overall 13 C-incorporation values (% 13 C-excess) into Ala:Asp:Glu of 39:6:7 in HeLa and 62:20:25 in Caco-2, respectively ( Fig. 2A and B, bars labeled with control). Nevertheless, the relative isotopologue compositions, i.e. the % fractions of isotopologues carrying a certain number of 13 C-atoms, were similar in Ala from HeLa or Caco-2, respectively, ( Fig. 2C and D Information Fig. S1 ). On the basis of the higher 13 C-enrichments in Ala from Caco-2 (62% overall 13 C-excess) glycolytic flow was apparently more pronounced in Caco-2 than in HeLa cells (39% overall 13 C- Indeed, the 13 C-isotopologue patterns of Asp and Glu were in agreement with this assumption (Supporting Information Fig. S2 ).
Next, we monitored the incorporation patterns of Ala, Asp and Glu from HeLa cells cultivated in the presence of 2 mM [U-
C 5 ]glutamine in addition to 10 mM unlabeled glucose using the same setting as described above. Whereas the 13 C-enrichment of Ala was low (< 2%), Asp and Glu showed significant C-enrichment in Ala, the formation of pyruvate or PEP via decarboxylation of oxaloacetate is rarely active under these conditions. In summary, the experiments with non-infected HeLa and CaCo-2 cells revealed differential usage rates of the major carbon nutrients, glucose and glutamine, for the cell types under study. On the basis of the detected isotopologue profiles, the relative contributions of glycolysis, the PPP, the TCA cycle and related anaplerotic reactions, respectively, could be assigned in considerable detail. The knowledge of these patterns and their underlying pathways and fluxes was important for the interpretation of the infection experiments described below.
Evidence for increased glucose and glutamine usage by host cells due to chlamydial infection
In order to estimate potential changes in these metabolic usages and pathways due to bacterial infection, HeLa or Caco-2 cells were first infected with C. trachomatis and then cultured for 24 h in the presence of [U-
13
C 6 ]glucose. After cultivation, bacteria were separated from the host cells by differential centrifugation, and the host cell fraction was again analyzed via protein hydrolysis, amino acid derivatization and GC/MS. For comparison, the same experimental settings were used for non-infected cells (Supporting Information Tables S7 and S8 ). As shown in Fig. 4A , Chlamydia infection slightly increased the 13 C-incorporation of [U-
C 6 ]glucose into Ala and Asp but less into Glu of the infected HeLa cells with 15% Ala in infected (bars labeled with HeLa infected) vs. 12% Ala in uninfected cells (bars labeled with HeLa control), 5% Asp in infected vs. 3% Asp in uninfected cells and 5% Glu in infected vs. 4% in uninfected cells. This increase may be caused by an increase in glucose uptake and glycolysis and/or the PPP of the host cell due to the infection. Since the cross-contamination rates of the fractions should be < 1% (Schunder et al., 2016) , it is save to assume that the observed increase in 13 C-incorporation is not due to a contamination by residual bacterial material in the host cell fraction. Further supporting this assumption, Caco-2 cells did not display a similar increase of 13 C-incorporation upon infection into Asp and Glu with 3% Asp and 4% Glu in infected vs. 4% Asp and 4% Glu in uninfected cells, respectively (Fig. 4B) . Ala from infected Caco-2 cells showed some increase in comparison to non-infected cells (Fig. 4B) . Table S9 ). Thus, the rates of glutaminolysis also appeared to be increased in the infected HeLa cells. In summary, glycolysis, glutaminolysis and/or the PPP were found to be slightly up-regulated in host cells due to the infection with intracellular C. trachomatis. Notably, both cancer cell lines, HeLa and Caco-2, in uninfected form already display high metabolic activities including glucose and glutamine metabolism that appear to be even more stimulated due to the bacterial infection.
Host amino acids serve as efficient precursors for proteins of intracellular C. trachomatis
To get more insights into the central carbon metabolism of intracellular C. trachomatis, we now analyzed the labeling profiles of the bacterial fractions from the infection experiments described above. A 'pre-labeling' setup was used to determine whether Chlamydia utilize glucose or glutamine from the cell culture medium (e. enriched tracer, and infected with C. trachomatis. After a further incubation period of 24 h in the non 13 C-enriched medium, bacteria were separated from host cell material. The bacterial pellets were hydrolyzed under acid conditions, the resulting amino acid were converted into TBDMS-derivatives, and finally analyzed by GC/MS following the same protocols described above for the analysis of host cell material.
If the bacteria were capable of synthesizing amino acids from unlabeled nutrients e.g. glucose and glutamine in the culture medium of the infected cells, they would be devoid of 13 C-enriched amino acids. Detection of bacterial protein-derived amino acids with an isotopic profile of the host's amino acids, however, would strongly indicate that these amino acids were ready-made taken up from the host i.e. in 13 C-labeled form of nonessential host amino acids and in unlabeled form of essential host amino acids for bacterial protein biosynthesis. As already shown above, significant 13 C-enrichments were observed under these conditions in the nonessential host amino acids Ala, Asp and Glu at levels of 30, 5 and 6%, respectively ( Fig. 2A, HeLa infected) . Chlamydia isolated from these host cells acquired 13 C-label in Ala, Asp and Glu at levels of 20, 3 and 5%, respectively ( Fig. 2A, Chlamydia) , and the isotopologue profiles of these bacterial amino acids were highly similar to those of the host cells (Fig. 2C) . Host-essential amino acids were apparently unlabeled in the bacterial proteins under these conditions (Supporting Information Table S2 ). The same label distributions and patterns in amino acids from HeLa and their intracellular C. trachomatis, respectively, were also observed when the host cells were pre-labeled with [1- Tables S4 and S5 ), indicating that ready-made amino acids were transferred from HeLa and used for bacterial protein biosynthesis.
The data were similar when Caco-2 cells were used as host cells. The ratios of 13 C-incorporation from [U-
C 6 ]glucose into Ala, Asp and Glu of the bacteria with 45%, 17%, and 19% (Fig. 2B , Chlamydia) were close to those in the Caco-2 host cells with 54%, 17% and 19% (Fig. 2B , Caco-2 infected). Again, the 13 C-isotopologue profiles of these host cell and bacterial amino acids were almost identical (Fig. 2D) . Together, the close correspondence of the 13 C-patterns in host and bacterial amino acids strongly suggests that the major fraction of amino acids in intracellular C. trachomatis was not made de novo from exogenous glucose or glutamine, but was rather imported from the host cells and directly used for protein biosynthesis.
It is not known whether Chlamydia can take up C 3 -glycolysis intermediates and asymmetric label might result in different isotopologue labeling patterns between bacteria and host cells reflecting different metabolic processes in the cells under study. However, labeling with [1- Tables S10 and S11 ), reflecting again that the labeled amino acids or their direct precursors synthesized in the host cells were taken up and incorporated unaltered into protein by C. trachomatis. Next, we tested in more detail whether glutamine from the host could be metabolized via the partial chlamydial TCA pathway (Stephens et al., 1998; Iliffe-Lee and McClarty, 2000) , and used as a precursor for partial de novo synthesis of Ala, Asp and Glu. For this purpose, we infected with C. trachomatis either In the 'prelabeling' approach (Fig. 3B , HeLa infected), about 50% of bacterial Glu and Asp were again labeled, whereas Ala showed a very low 13 C-label (< 2%). The 13 Cisotopologue profiles of these amino acids were highly similar to those observed in the uninfected HeLa cells (Fig. 3D) . The same observation could be made when the infected cells were incubated for 24 h in the presence of [U-
C 5 ]glutamine ( Fig. 3A and C) . Although the biological replicates resulted in high deviations of the values for bacterial amino acids, the data were in line with the assumption that glutamine did not contribute to the de novo biosynthesis of Ala, Asp and Glu in intracellular C. trachomatis.
Minor fractions of bacterial amino acids are made de novo e.g. from a host TCA dicarboxylate
In order to more generally address the question of a potential de novo synthesis or metabolic turnover of amino acids imported from the host cell by C. trachomatis, we used an experimental setting where C. trachomatis-infected HeLa cells were cultivated for 24 h in a similar culture medium as described above, however C]-labeled amino acids. Our GC/MS analyses of this commercial mix confirmed that most proteinogenic amino acids were present in this mix at similar molar amounts, but the acid-labile amino acids, tryptophan, glutamine and asparagine were missing. Isotope analysis demonstrated that each of the amino acids in the mixture had > 98% 13 C-enrichments.
Among the analyzed amino acids of C. trachomatis, the essential amino acids Ile, Leu Val, Phe were highly labeled (see Fig. 5A for Val and Supporting Information Table S12 ) and the isotopologue profiles of these amino acids retained the 100% 13 C-label of the originally added labeled amino acids (see Fig. 5B for Val). The situation was different for Ala, and especially for Asp and Glu, where much lower 13 C-excess was found with about 13% for Ala and 4% for Asp and Glu (Fig. 5A) . Moreover, the isotopologue profiles of these amino acids were now significantly changed, especially of Asp and Glu in comparison to the same amino acids isolated from the host cell fraction (Fig. 5B) (Fig. 5B ). These results indicate (i) a higher de novo synthesis of Asp and Glu in the bacteria than in the host cells and (ii) a different quantitative usage of 13 Clabeled precursors, oxaloacetate and oxoglutarate, respectively, for the synthesis of Asp and Glu in the two interacting partners. Of major importance is the considerably higher amount of the M 1 3, M 1 2 and M1 1 isotopologues in Glu and Asp in C. trachomatis than in the host cells. Since there are no possible reactions in C. trachomatis due to the incomplete TCA cycle (see Fig. 1 ) leading to the observed 13 C 1 -, 13 C 2 -and 13 C 3 -oxaloacetate and oxoglutarate precursors, e.g. by multiple cycling in the TCA pathway, these differently labeled precursors must have been produced in the host cells, taken up by the bacteria, and finally, transaminated to the respective 13 C-labeled isotopologues of Asp and Glu. Indeed, these results support a scenario where TCA dicarboxylic acids from the host cell, displaying the M 1 2 and M 1 3 signatures, could be taken up by growing C. trachomatis as additional carbon substrates. The detection of minor fractions of 13 C 2 -and 13 C 1 -isotopologues in Ala of C. trachomatis (Fig. 5B) further suggests that the host cell-derived TCA intermediates can also be converted at low rates via the PckA-catalyzed reaction into PEP and further into pyruvate/Ala.
Malate can be efficiently taken up and metabolized by C. trachomatis
To provide more experimental evidence for the potential uptake of a TCA-derived dicarboxylate from the host by C. trachomatis, we applied 1 mM [U-
13
C 4 ]malate for 24 h to infected HeLa cells and again determined the labeling patterns of protein derived amino acids from the host and the bacterial fractions respectively. It turned out that all amino acids under study from both fractions were apparently unlabeled (< 0.5% 13 C-excess, Supporting Information Table S13 ). We concluded that the malate tracer was not incorporated into the host cells to serve as an precursor for host cell amino acids, e.g. aspartate via oxaloacetate and consequently as a carbon substrate for the intracellular bacteria. Indeed, when HeLa cells were cultivated in RPMI medium containing 1 mM malate, the concentration of exogenous malate did not drop within 24 h (Supporting Information Table S14 ). In contrast, when intracellular C. trachomatis were isolated and transferred into axenic medium containing 1 mM malate, 60% of malate were consumed already after 2 h (Fig. 6A) . Using [U- Table  S15 ) clearly demonstrated that malate could be taken up by C. trachomatis and metabolized in the partial citrate cycle of the bacterium as a prerequisite to serve as a carbon substrate via oxaloacetate for aspartate biosynthesis and downstream pathways (e.g. mDAP for peptidoglycan synthesis). Not surprisingly, however, 13 C-label from malate could not be found in protein-derived amino acids nor in mDAP, since C. trachomatis does not multiply under the conditions of the labeling experiment in the axenic medium (Omsland et al., 2012) and apparently does not synthesize protein or cell wall components under these conditions.
Glucose serves an efficient precursor for LPS in intracellular Chlamydia As described above, the labeling experiments using [U-
C 6 ]glucose as a tracer showed that C. trachomatis does not significantly synthesize amino acids from glucose or related downstream sugars or sugar phosphates during intracellular growth despite encoding some of the respective enzymatic capability. To now test whether intracellular growing Chlamydia nevertheless utilizes glucose or related compounds (for example, its phosphates) for other metabolic purposes, we tested whether 13 C-label from exogenous [U-
C 6 ]glucose could be transferred into the bacterial lipopolysaccharides (LPS). For this purpose, HeLa cells were infected with C. trachomatis and then cultivated for 48 h in medium containing 10 mM [U-
C 6 ]glucose. In a control experiment, the infected cells were cultivated in the same medium without labeled glucose, but containing 10 mM unlabeled glucose. Subsequently, the bacteria were isolated as described above and LPS was extracted. The extracts were directly analyzed by ESI-FT-ICR mass spectrometry where intact molecular ions of LPS (Fig. 7A ) and fragment ions of its lipid A (Fig.  7B ) and core oligosaccharide moiety (Fig. 7C) , respectively, were analyzed. MS spectra of LPS from unlabeled bacteria (shown in blue) were in agreement with published data for LPS in C. trachomatis (Rund et al., 1999) . The most abundant LPS mono isotopic peak at m/z 2494.49 (Fig. 7A ) was assigned to the core oligosaccharide (3Kdo) linked to a penta-acylated lipid A (consisting of 2 GlcN, 2 P, 2 OH-C20:0, 2 C14:0 and 1 C20:1). Due to variation in the chain length of the fatty acid residues, LPS and lipid A showed heterogeneity of Dm 5 6 14 Da. The mass spectra of LPS from [U- C can roughly be estimated to 78% 13 C-excess. For the lipid A fragment carrying 100 C atoms, the same average incorporation rate was estimated. For the core tri-saccharide fragment (Kdo 3 ) with an elemental composition of (C24, H36, O21), we found isotopic peaks indicating 16 -23 13 C exchanges and a highly abundant peak at m/z 683.249 with almost complete 13 C-excess. Taken together, these data clearly demonstrate that 13 C-label from [U-
C 6 ]glucose was very efficiently shuffled into the chlamydial LPS during intracellular growth, which is in agreement with the uptake of glucose-6P and its metabolic processing into polysaccharides. Thus, it can be assumed that exogenous glucose was taken up by the host cells, where it was converted into its 6-phosphate that was shuffled into the bacterial cells by the UhpC transporter (Schwoppe et al., 2002) , and then very efficiently used as a precursor for the biosynthesis of bacterial polysaccharides.
Discussion
To gain insights into the metabolic adaptation processes which enable C. trachomatis to successfully replicate within mammalian host cells, we have exploited the 13 Cisotopologue profiling method, a powerful technology allowing the assessment of carbon utilization by intracellular bacteria. The method is mostly based on the comparison of the isotopologue compositions in amino acids or other metabolic products from the host cell fraction vs. the bacterial fraction (Eisenreich et al., 2010) . For example, deviations between the labeling patterns of host and bacterial amino acids would be indicative of a preferential metabolic activity involved in the bacterial pathways for amino acids and their precursors (Eylert et al., 2008) . On the basis of this comparative approach, labeling experiments using C. trachomatis-infected HeLa or Caco-2 cells supplied with 13 C-glucose, 13 C-glutamine, or a mix of 13 C-amino acids demonstrated the predominant usage of host amino acids for bacterial protein biosynthesis (see Fig. 8 ). This result is in line with genomic data showing the absence of most anabolic pathways, including those for all essential amino acids, but displaying several putative transporters for amino acids. However, some significant deviations in the labeling profiles of host and bacterial Ala, Asp and Glu indicated that at least a fraction of these amino acids can be made de novo from other host nutrients (metabolites), most probably from one or more host TCA-derived dicarboxylates such as malate, oxaloacetate or oxoglutarate. In line with this assumption, we could show that exogenous malate was efficiently taken up and metabolized via the partial TCA cycle of C. trachomatis. The presence of the putative dicarboxylate translocator SodTi in C. trachomatis is in further support of this hypothesis (Allan and Pearce, 1983; Kuo and Grayston, 1990; Stephens et al., 1998) . Interestingly, prior to or during the early replicative phase, C. trachomatis depends on the synthesis of the A1g-type peptidoglycan carrying meso-diaminopimelate (mDAP) as a crosslinker (Packiam et al., 2015) . Bacterial de novo biosynthesis of mDAP appears to be essential, since this compound cannot be made by mammalian host cells. The basic precursor of bacterial mDAP biosynthesis is aspartate that is converted into mDAP by several steps following reactions of lysine biosynthesis. Notably, enzymes catalyzing the conversion of Asp into mDAP (but not further into Lys) are also present in C. trachomatis on the basis of the genome sequence. Capitalizing on this fact, the supply of dicarboxylates from the host cell into the partial TCA cycle of C. trachomatis could fill up the pool of free aspartate by providing its immediate precursor oxaloacetate or malate. Thus, the usage of these dicarboxylates from the host would guarantee the efficient formation of mDAP and peptidoglycan when required during intracellular growth. In conclusion, this control of metabolic flux could represent another prime example of the metabolic adaptation of intracellular pathogens to their host cells. Interestingly, ESI-FT-ICR-MS analysis of chlamydial LPS showed that label from [U- 13 C 6 ]glucose present in the medium of C. trachomatis-infected HeLa cells was very efficiently transferred into the bacterial polysaccharides affording 13 C-enrichments of > 75% in LPS. C. trachomatis does not possess known transporters for glucose or other hexoses, but glucose-6P can be efficiently taken up by the UhpC transporter (Stephens et al., 1998) . It can therefore be assumed that glucose-6P (made in the host cell from the proffered 13 C-glucose) was efficiently imported from the host cell into the intracellular bacteria. Downstream formation and processing of LPS requires an at least partially active glycolysis and PPP. The detected intracellular growing Chlamydia (Fig. 7) . However, glucose-6P did not significantly support the de novo biosynthesis of amino acids in C. trachomatis, as seen by the comparative isotopologue analysis of host cell and bacterial amino acids.
Taken together, we have shown for the first time cosubstrate usage by intracellularly replicating C. trachomatis taking glucose-6P from the host as an essential carbon source for polysaccharide biosynthesis (e.g. LPS), host amino acids for the bacterial protein biosynthesis, and, probably host dicarboxylates such as malate for feeding the partial chlamydial TCA cycle, probably to provide precursors for mDAP and hence peptidoglycan. Our data support the model that C. trachomatis utilizes a bipartite metabolism (Fig. 8 ) similar to intracellular Listeria monocytogenes (Grubm€ uller et al., 2014) and Legionella pneumophila (H€ auslein et al., 2015; Gillmaier et al., 2016) . In all of these metabolic networks, different carbon sources and metabolites are efficiently channeled from the host into the bacterial metabolism for production of biomass (e.g. protein and cell wall biosynthesis) and energy. This model of co-substrate usage in a partite metabolism could therefore reflect a general feature in the adaptation process of intracellular pathogens and their host that may finally provide metabolic robustness for the bacteria and decrease the metabolic burden for the host cells. In support of this hypothesis, metabolic regulation by catabolite repression found in many bacteria to streamline metabolism for the usage of a single carbon nutrient (G€ orke and St€ ulke, 2008) , appears to be missing in Chlamydia (Iliffe- Lee and McClarty, 2000; Nicholson et al., 2004) .
Based on closely related genome sequences of C. trachomatis and other pathogenic Chlamydiae (Subtil et al., 2014) , it can be assumed that co-substrate usage in a bipartite metabolism is also operative in other pathogenic Chlamydiae. Metabolic adaptation in response to the Chlamydia infection seems to occur in the host cell as well, as shown by the increased glucose and glutamine usage of the C. trachomatis-infected HeLa and Caco-2 cells. Since most cancer cell lines including HeLa and Caco-2 already display de-regulated metabolic fluxes with e.g. high rates of glucose and glutamine consumption, it can be assumed that these host responses may be much more pronounced in primary differentiated cells that are typically infected by C. trachomatis. Future research will therefore be aimed at studying primary host cells together with the implementation of further readouts to fully delineate nutrient usage and carbon fluxes in intracellular Chlamydiae and related bacteria in mutual adaption to their host cells.
Experimental procedures
Cell lines, bacteria and chemicals HeLa229 (ATCC CCL-2.1) and Caco-2 (ATCC HTB-37) were grown in RPMI-1640 medium (5 mM L-glutamine, 10% FBS, w/o HEPES) (Invitrogen). C. trachomatis L2/434/ Bu was cultured and purified as described previously (Mehlitz et al., 2010) . Briefly, HeLa229 cells grown to 50-70% confluency were inoculated with C. trachomatis in RPMI-1640 containing 5% FBS for 2 h at 358C in a humidified incubator at 5% CO 2 . Medium was replaced by infection medium (RPMI-1640, 5 mM L-glutamine, 5% FBS, 2 mg/ml cycloheximide, w/o HEPES) and growth was allowed for 2 days. Cells were mechanically detached and bacteria were released using $2-5 mm glass beads (Carl Roth). Low speed supernatant (2,000 g, 48C and 5 min) was subjected to high-speed centrifugation (40,000 g, 48C and 25 min) to pellet bacteria. Bacteria were washed twice with 10 ml SPG (250 mM sucrose, 50 mM sodium phosphate, 5 mM glutamate, pH 7.4), aliquoted and stored at 2808C in SPG. Chemicals including the 13 C-labeled precursors were obtained from Sigma-Aldrich (Germany). C 4 ]malate (with 10 mM unlabeled glucose and 2 mM unlabeled glutamine). Labeling was either done before or during infection as indicated. At 50-70% confluency, cells were infected with C. trachomatis (MOI2); therefore, medium was exchanged to RPMI-1640 (5% FBS, w/o HEPES 1 respective unlabeled or 13 C-tracer 1 2 mg/ml cycloheximide). Twenty-four h post infection, supernatant was reduced to 10 ml per dish and cells were detached with a rubber policeman. Bacteria were released from the cells by vortexing for 1 min with 2-5 mm glass beads. Cell debris was removed at low speed (2,000 g, 4-88C and 10 min) and pellet was frozen at 2808C and analyzed as host fraction. The supernatant was subjected to high-speed centrifugation (40,000 g, 4-88C, 30 min) and the pellet was washed once with 10 ml hanks balanced salt solution (HBSS, Invitrogen, Gibco) at 40,000 g, 4-88C and 30 min. Bacteria pellets were resuspended in 5 ml of HBSS media and passaged three times through a G22 and G18 syringe to disperse the bacteria. Purification was completed by centrifugation through a Renografin cushion via ultracentrifugation. The bacterial suspension (5 ml) was carefully placed on 7.5 ml of 30% Renografin followed by centrifugation (80,000 g, 60 min, 4-88C). The bacterial pellet was washed with 1 ml of HBSS at 21,500 g, 4-88C and 30 min and stored at 2808C and was analyzed as the bacterial fraction (Chlamydia in Figs 2-6 ).
Analysis of malate uptake by HeLa cells
HeLa229 cells were seeded in a culture plate in RPMI-1640 (Invitrogen, 10% FCS) containing 1 mM malate. At intervals (0, 2, 5, 24 h), 1 ml of the supernatant was taken and stored at 2808C. The concentration of malate was then determined by GC/MS (see below).
Labeling experiments using C. trachomatis in axenic medium
HeLa229 cells were seeded in a culture plate (RPMI-1640 (Invitrogen), 10% FCS). At a confluency of 50-60%, cells were infected with C. trachomatis (MOI 2); thereafter, medium was exchanged to 5% FCS RPMI-1640 (Invitrogen). Twenty-four h post infection, the supernatant was reduced to 10 ml and the cells were lysed for bacterial preparation as mentioned above. The supernatant was subjected to highspeed centrifugation at 25,000 g (30 min, 48C) and the bacterial pellet was washed once with 10 ml SPG-buffer (sucrose-phosphate-glutamate-buffer) at 25.000 g (30 min, 48C). Bacteria were resuspended in 2 ml of either unlabeled RPMI-1640 or RPMI-1640 containing 1 mM [U-
13
C 4 ] Lmalate (RPMI-1640 (Invitrogen), 10% FCS, 1 mM L-Malic acid). The bacteria were passed three times through a G22 and G18 syringe in order to disperse the bacteria. 0.5 mM glucose 6-phosphate was added to the medium. 1 ml of the culture was centrifuged at 21,500 g (30 min, 48C), the pellet was resuspended, and the bacteria were incubated for 2 h at 378C. After 2 h, 1 ml of the culture was again centrifuged at 21,500 g (30 min, 48C). All sampled were heat inactivated (908C 10 min) and stored at 2808C for analyses.
Protein hydrolysis, amino acid derivatization and gas chromatography/mass spectrometry (GC/MS) Samples were heat inactivated before analysis (908C, 10 min). Protein hydrolysis, amino acid derivatization and GC/ MS were done as described previously (Gillmaier et al., 2012) . 13 C excess in succinate, fumarate and malate were analyzed from the cation exchange wash water solution and amino acids were analyzed from the ammonium hydroxide eluate. Derivatization of the carboxylic acids was identical to the amino acid derivatization. For the carboxylic acid derivatives the GC-column was developed at 1008C for 2 min and then with a temperature gradient of 38C/min to a final temperature of 2608C. Overall 13 C-excess was calculated from isotopologue data as follows:
Metabolism of intracellular chlamydia trachomatis 1017 ð Þ1 M12 ð ÞÃ21 M13 ð ÞÃ3 Ã 1 . . . . . . :1 M1n ð ÞÃ n ð Þ=n with n 5 number of carbon atoms of the amino acid. Malate quantification was done with an 0.5 ml aliquot of the medium in the presence of 0.1 mmol norvaline as internal standard. Samples were dried under a gentle stream of nitrogen, derivatized as TBDMS derivatives and analyzed with GC/ MS with a starting temperature of 908C and a temperature gradient of at 108C/min to a final temperature of at 2808C.
Isolation and mass spectrometric analysis of C. trachomatis LPS The isolated bacterial pellets (wet mass, 21 mg each), were heat-inactivated at 948C for 30 min, dried, and the LPS extracted according to the phenol-chloroform-petroleum ether procedure (Galanos et al., 1969) . Without further purification, aliquots of the dried LPS samples were dissolved at a concentration of $10 ng/ml in a 50:50:0.001 (v/v/v) mixture of 2-propanol, water and triethylamine and analyzed by electrospray ionization Fourier transform ion cyclotron (ESI-FT-ICR) mass spectrometry using an APEX QE (Bruker Daltonics) in the negative ion mode as described previously (Kondakov and Lindner, 2005; Klein et al., 2011) .
